Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Role of innate and adaptive cytokines in the survival of COVID-19 patients

  • Monserrat Sanz, Jorge|||0000-0003-1775-4645
  • Gómez Lahoz, Ana María|||0000-0003-3981-5138
  • Ortega Núñez, Miguel Ángel|||0000-0003-2588-1708
  • Sanz, José
  • Muñoz Calvo, Benjamín Francisco
  • Arévalo Serrano, Juan|||0000-0003-2563-7860
  • González-Moro Rodríguez, José Miguel|||0000-0002-8446-3373
  • Gasalla Herráiz, José Manuel
  • Gasulla Montardit, Óscar
  • Arranz Caso, José Alberto
  • Fortuny Profitós, Jordi
  • Mazaira Font, Ferrán Antonio
  • Teixidó Román, Miguel
  • Martínez Alonso, Carlos
  • Balomenos, Dimitri
  • Asúnsolo Del Barco, Ángel|||0000-0001-7898-4685
  • Álvarez De Mon Soto, Melchor|||0000-0003-1309-7510
20 p., The Covid-Hupa Group, Abstract: SARS-CoV-2 is a new coronavirus characterized by a high infection and transmission capacity. A significant number of patients develop inadequate immune responses that produce massive releases of cytokines that compromise their survival. Soluble factors are clinically and pathologically relevant in COVID-19 survival but remain only partially characterized. The objective of this work was to simultaneously study 62 circulating soluble factors, including innate and adaptive cytokines and their soluble receptors, chemokines and growth and wound-healing/repair factors, in severe COVID-19 patients who survived compared to those with fatal outcomes. Serum samples were obtained from 286 COVID-19 patients and 40 healthy controls. The 62 circulating soluble factors were quantified using a Luminex Milliplex assay. Results. The patients who survived had decreased levels of the following 30 soluble factors of the 62 studied compared to those with fatal outcomes, therefore, these decreases were observed for cytokines and receptors predominantly produced by the innate immune system?IL-1?, IL-1?, IL-18, IL-15, IL-12p40, IL-6, IL-27, IL-1Ra, IL-1RI, IL-1RII, TNF?, TGF?, IL-10, sRAGE, sTNF-RI and sTNF-RII?for the chemokines IL-8, IP-10, MCP-1, MCP-3, MIG and fractalkine; for the growth factors M-CSF and the soluble receptor sIL2Ra; for the cytokines involved in the adaptive immune system IFN , IL-17 and sIL-4R; and for the wound-repair factor FGF2. On the other hand, the patients who survived had elevated levels of the soluble factors TNF?, sCD40L, MDC, RANTES, G-CSF, GM-CSF, EGF, PDGFAA and PDGFABBB compared to those who died. Conclusions. Increases in the circulating levels of the sCD40L cytokine; MDC and RANTES chemokines; the G-CSF and GM-CSF growth factors, EGF, PDGFAA and PDGFABBB; and tissue-repair factors are strongly associated with survival. By contrast, large increases in IL-15, IL-6, IL-18, IL-27 and IL-10; the sIL-1RI, sIL1RII and sTNF-RII receptors; the MCP3, IL-8, MIG and IP-10 chemokines; the M-CSF and sIL-2Ra growth factors; and the wound-healing factor FGF2 favor fatal outcomes of the disease., Comunidad de Madrid, Universidad de Alcalá, ProA Capital, Halekulani S.L., MJR, Fundación Startlite
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Prognostic factors of survival in patients with peritoneal metastasis from colorectal cancer

  • Mendoza Moreno, Fernando|||0000-0002-1046-6344
  • Díez Alonso, Manuel Mariano|||0000-0002-0993-8498
  • Matías García, Belén
  • Ovejero Merino, Enrique|||0000-0002-4254-3594
  • Gómez Sanz, María de los Remedios|||0000-0002-0049-5870
  • Blázquez Martín, Alma
  • Quiroga Valcárcel, Ana
  • Vera Mansilla,Cristina
  • Molina Villaverde, Raquel
  • San Juan, Alberto
  • Barrena Blázquez, Silvestra|||0000-0003-2715-1979
  • Ortega Núñez, Miguel Ángel|||0000-0003-2588-1708
  • Álvarez de Mon Soto, Melchor|||0000-0003-1309-7510
  • Gutiérrez Calvo, Alberto José|||0000-0003-3751-5676
Objectives: The aim of this study was to analyze the prognostic factors of survival in patients with peritoneal metastasis (PM) from colorectal cancer (CRC). The type of relationship between survival and the PM time of detection was used to determine whether it was synchronous with the primary tumor or metachronous. Patients and Methods: Retrospective observational study. It included patients treated for colorectal adenocarcinoma diagnosed between January 2005 and December 2019 who presented PM at the time of diagnosis or during follow-up. Variables, such as sex, age, differentiation grade, positive adenopathy (pN+), tumor size (pT), tumor location, mucinous component, peritoneal carcinomatosis index (PCI), and KRAS mutational status, were analyzed. Results: During the study period, 1882 patients were surgically treated for CRC in our hospital. Of these, 240 patients (12.8%) were included in the study after evidence of PM. The mean age was 67 ± 12 years (range: 32–92 years), and 114 patients were female (47.5%). The mean follow-up was 20 ± 13 months (median 12 months). The Kaplan–Meier survival at 36 months was higher in patients with metachronous PM (24% vs. 8%; p = 0.002), WT-KRAS tumors (31% vs. 15%; p < 0.001), N0 stage (30% vs. 19%; p < 0.001), T3 stage tumors (18% vs. 19% in T4A and 3% in T4B; p > 0.001), and tumors with classic adenocarcinoma histology (18% vs. 8%; p = 0.011). Patients with a PCI of 1–10 showed a likelihood of survival at 36 months of 56%, which was longer than that found in patients with a PCI of 11–20 (8%) or a PCI of >20 (0%) (p < 0.001). In the multiple regression analysis, the factors with an independent prognostic value were: poor grade of differentiation (HR 1.995; 95% CI: 1.294–3.077), KRAS mutation (HR 1.751; 95% CI: 1.188–2.581), PCI 11–20 (HR: 9.935; 95% CI: 5.204–18.966) and PCI > 20 (HR: 4.011; 95% CI: 2.291–7.023). Conclusions: PCI should continue as the as the most useful prognostic indicator in order to assess prognostic estimations as well as therapeutic and surgical decisions, but tumor grade and KRAS mutational status may help in the treatment decision process by providing complementary information. The time of PM detection did not achieve statistical significance in the multiple regression analysis., Comunidad de Madrid
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Oxidative stress markers are associated with a poor prognosis in patients with pancreatic cancer

  • Ortega Núñez, Miguel Ángel|||0000-0003-2588-1708
  • Fraile Martínez, Óscar|||0000-0002-4494-6397
  • Pekarek, Leonel|||0000-0002-5966-9003
  • Burgos Fraile, Enrique
  • García Montero, Cielo|||0000-0001-6016-7855
  • Álvarez de Mon González, Miguel Ángel|||0000-0002-1987-0394
  • Jiménez Castellanos, Alejandro
  • García Honduvilla, Natalio Antonio|||0000-0003-0904-6198
  • Buján Varela, María Julia Araceli|||0000-0003-2419-2476
  • Álvarez De Mon Soto, Melchor|||0000-0003-1309-7510
  • Sáez García, Miguel Ángel|||0000-0002-8389-258X
  • González Guijarro, Luis Alberto|||0000-0003-4979-2136
  • Asúnsolo Del Barco, Ángel|||0000-0001-7898-4685
11 p., Pancreatic cancer is a malignancy of rising prevalence, especially in developed countries where dietary patterns and sedentariness favor its onset. This malady ranks seventh in cancer-related deaths in the world, although it is expected to rank second in the coming years, behind lung cancer. The low survival rate is due to the asymptomatic course of the early stages, which in many cases leads to metastases when becoming evident in advanced stages. In this context, molecular pathology is on the way towards finding new approaches with biomarkers that allow a better prognosis and monitoring of patients. So the present study aims to evaluate a series of molecular biomarkers, PARP1, NOX1, NOX2, eNOS and iNOS, as promising candidates for prognosis and survival by using immunohistochemistry. The analysis performed in 41 patients with pancreatic cancer showed a correlation between a high expression of all these components with a low survival rate, with high statistical power for all. In addition, a 60-month longitudinal surveillance program was managed, accompanied by several clinical parameters. The derivative Kaplan?Meier curves indicated a low cumulative survival rate as well. Ultimately, our research emphasized the value of these molecules as survival-associated biomarkers in pancreatic cancer, offering new gates for clinical management., HALEKULANI, S.L., Comunidad de Madrid
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Chronic venous disease in pregnant women causes an increase in ILK in the placental villi associated with a decrease in E-Cadherin

  • Ortega Núñez, Miguel Ángel|||0000-0003-2588-1708
  • Chaowen, Chen
  • Fraile Martínez, Óscar|||0000-0002-4494-6397
  • García Montero, Cielo|||0000-0001-6016-7855
  • Sáez García, Miguel Ángel|||0000-0002-8389-258X
  • Cruza Aguilera, Iris
  • Pereda Cerquella, Claude
  • Álvarez De Mon González, Miguel Ángel|||0000-0002-1987-0394
  • González Guijarro, Luis Alberto|||0000-0003-4979-2136
  • Fatych Boboshko, Yuliia
  • Menor Salvan, César Ángel|||0000-0002-1238-190X
  • Álvarez de Mon Soto, Melchor|||0000-0003-1309-7510
  • De León Luis, Juan Antonio
  • Buján Varela, María Julia Araceli|||0000-0003-2419-2476
  • García Honduvilla, Natalio Antonio|||0000-0003-0904-6198
  • Bravo Arribas, Coral
  • Asúnsolo Del Barco, Ángel|||0000-0001-7898-4685
11 p., Chronic venous disease (CVD) is a multifactorial vascular disorder frequently manifested in lower limbs in the form of varicose veins (VVs). Women are a vulnerable population for suffering from CVD, especially during pregnancy, when a plethora of changes occur in their cardiovascular system. Previous studies have indicated a worrisome association between CVD in pregnancy with the placental structure and function. Findings include an altered cellular behavior and extracellular matrix (ECM) composition. Integrin-linked kinase (ILK) is a critical molecule involved in multiple physiological and pathological conditions, and together with cadherins, is essential to mediate cell to ECM and cell to cell interplay, respectively. Thus, the aim of this study was to evaluate the implication of ILK and a set of cadherins (e-cadherin, cadherin-6 and cadherin-17) in placentas of women with CVD in order to unravel the possible pathophysiological role of these components. Gene expression (RT-qPCR) and protein expression (immunohistochemistry) studies were performed. Our results show a significant increase in the gene and protein expression of ILK, cadherin-6 and cadherin-17 and a decrease of e-cadherin in the placenta of women with CVD. Overall, this work shows that an abnormal expression of ILK, e-cadherin, cadherin-6 and cadherin-17 may be implicated in the pathological changes occurring in the placental tissue. Further studies should be conducted to determine the possible associations of these changes with maternal and fetal well-being., Insituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional (FEDER), Comunidad de Madrid, Halekulani S.L.